Clinical Trial Update: Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid Malignancies [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports safety and efficacy findings from a Phase 1/2 study of Y-90 Zevalin (ibritumomab tiuxetan) used in nonmyeloablative transplan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma

Drugs mentioned

• Zevalin (ibritumomab tiuxetan)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lymphoma, Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-06-13